These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 2901759

  • 1. Differential alteration in striatal dopaminergic and cortical serotonergic receptors induced by repeated administration of haloperidol or centbutindole in rats.
    Gulati A, Srimal RC, Dhawan BN.
    Pharmacology; 1988; 36(6):396-404. PubMed ID: 2901759
    [Abstract] [Full Text] [Related]

  • 2. Effect of melanotropin release inhibiting factor on changes by haloperidol and centbutindole in cerebral cortical 5-hydroxytryptamine receptors.
    Gulati A, Bhargava HN.
    Pharmacology; 1990; 41(2):98-106. PubMed ID: 1979878
    [Abstract] [Full Text] [Related]

  • 3. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
    Rupniak NM, Kilpatrick G, Hall MD, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
    [Abstract] [Full Text] [Related]

  • 4. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S, Rupniak NM, Hall MD, Jenner P, Marsden CD.
    Biochem Pharmacol; 1983 Oct 01; 32(19):2921-7. PubMed ID: 6138043
    [Abstract] [Full Text] [Related]

  • 5. Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment.
    Jenner P, Rupniak NM, Hall MD, Dyer R, Leigh N, Marsden CD.
    Eur J Pharmacol; 1981 Nov 19; 76(1):31-6. PubMed ID: 6119220
    [Abstract] [Full Text] [Related]

  • 6. Elevation of circulating prolactin concentrations may not cause striatal dopamine receptor supersensitivity.
    Rupniak N, Hong M, Mansfield S, Fleminger S, Dyer R, Jenner P, Marsden CD.
    Eur J Pharmacol; 1983 Sep 30; 93(3-4):195-200. PubMed ID: 6139285
    [Abstract] [Full Text] [Related]

  • 7. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA, Szczepanik AM.
    Brain Res; 1989 May 22; 487(2):288-98. PubMed ID: 2525063
    [Abstract] [Full Text] [Related]

  • 8. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
    Rupniak NM, Hall MD, Mann S, Fleminger S, Kilpatrick G, Jenner P, Marsden CD.
    Biochem Pharmacol; 1985 Aug 01; 34(15):2755-63. PubMed ID: 4040370
    [Abstract] [Full Text] [Related]

  • 9. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.
    Pert A, Rosenblatt JE, Sivit C, Pert CB, Bunney WE.
    Science; 1978 Jul 14; 201(4351):171-3. PubMed ID: 566468
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of chronic clorgyline and amfonelic acid on desensitization of striatal dopamine receptors.
    Meller E, Bohmaker K, Friedhoff AJ.
    Life Sci; 1984 Oct 29; 35(18):1829-38. PubMed ID: 6492992
    [Abstract] [Full Text] [Related]

  • 11. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
    Jenner P, Rupniak NM, Marsden CD.
    Psychopharmacology Suppl; 1985 Oct 29; 2():174-81. PubMed ID: 3159009
    [Abstract] [Full Text] [Related]

  • 12. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM, Matvienko OA, Nurk AM.
    Biull Eksp Biol Med; 1984 Oct 29; 98(10):444-6. PubMed ID: 6541951
    [Abstract] [Full Text] [Related]

  • 13. Chronic haloperidol treatment potentiates apomorphine- and ethanol-induced hypothermia in the rat.
    Lai H, Kazi MS, Carino MA, Horita A.
    Life Sci; 1982 Mar 08; 30(10):821-6. PubMed ID: 7200179
    [Abstract] [Full Text] [Related]

  • 14. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
    Jenner P, Hall MD, Murugaiah K, Rupniak N, Theodorou A, Marsden CD.
    Biochem Pharmacol; 1982 Feb 01; 31(3):325-8. PubMed ID: 7200363
    [Abstract] [Full Text] [Related]

  • 15. [Changes in the sensitivity of brain dopamine and serotonin receptors during the prolonged administration of carbidine].
    Zharkovskiĭ AM, Chereshka KS, Zharkovskaia TA, Allikmets LKh.
    Biull Eksp Biol Med; 1985 Dec 01; 100(12):719-22. PubMed ID: 2866801
    [Abstract] [Full Text] [Related]

  • 16. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
    Korf J, Sebens JB.
    J Neurochem; 1987 Feb 01; 48(2):516-21. PubMed ID: 2878979
    [Abstract] [Full Text] [Related]

  • 17. Prolonged inhibition of striatal dopamine receptor sites by isofloxythepin.
    Lau YS, Runice C.
    Eur J Pharmacol; 1985 Oct 08; 116(1-2):25-31. PubMed ID: 2865162
    [Abstract] [Full Text] [Related]

  • 18. Chronic molindone treatment: relative inability to elicit dopamine receptor supersensitivity in rats.
    Meller E.
    Psychopharmacology (Berl); 1982 Oct 08; 76(3):222-7. PubMed ID: 6808540
    [Abstract] [Full Text] [Related]

  • 19. Striatal dopamine receptor supersensitivity after long-term haloperidol treatment of hypophysectomized rats.
    DeLucia R, Scavone C, Camillo MA.
    Braz J Med Biol Res; 1989 Oct 08; 22(6):741-3. PubMed ID: 2620186
    [Abstract] [Full Text] [Related]

  • 20. Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
    Allen RM, Lane JD, Brauchi JT.
    Eur J Pharmacol; 1980 Jul 25; 65(2-3):313-5. PubMed ID: 7190503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.